CT导引下微波消融治疗少血供型肝癌的临床应用  

Clinical application of CT guided microwave ablation for the treatment of hypovascular liver cancer

作　　者：左太阳[1] 许淑玲[1] 张忠涛[1] 刘宗花 张楠[1] 

机构地区：[1]山东大学齐鲁医院平邑分院,山东273300 [2]临沂市罗庄区人民医院,山东276000

出　　处：《放射学实践》2015年第11期1130-1133,共4页Radiologic Practice

摘　　要：目的:探讨CT导引下微波消融治疗少血供型肝癌的临床应用价值。方法:选择通过CT增强扫描并经穿刺活检病理证实的少血供型肝癌36例,行CT导引下微波治疗。分析术后3、6、12、24个月的AFP变化情况、肿瘤局部控制率及生存率。结果:36例少血供肝癌患者治疗后3、6、12、24个月AFP下降的患者比例依次是100%(36/36),100%(36/36),88.9%(32/36),80.6%(29/36),肿瘤局部控制率依次是100%(36/36),97.2%(35/36),88.9%(32/36),83.3(30/36),生存率依次是100%(36/36),100%(36/36),94.4%(34/36),88.9%(32/36)。结论:CT导引下微波消融治疗少血供型肝癌,定位准确、疗效可靠,是提高肿瘤局部控制率和生存率的有效方法。Objective：To study the clinical application of CT guided microwave ablation for the treatment of hypovas cular liver cancer. Methods： Thirty-six cases of hypovascular liver cancer assessed by enhanced CT and proved by biopsy were treated by CT guided microwave ablation therapy. The rates of change of AFP values,local tumor control and survival were analyzed. Results：The rate of decrease of AFP values in 3,6,12 and 24 months after treatment for 36 cases of hypovas cular liver cancer was 100% （36/36）,100% （36/36） ,88.9% （32/36） ,80.6% （29/36） respectively,the local tumor control rate was 100% （36/36）,97.2% （35/36） （32/36,88.9%）,83.3 （30/36） respectively,survival rate was100% （36/36）, 100% （36/36） ,94.4% （34/36） ,88.9% （32/36） ,respectively. Conclusion：CT guided microwave ablation could be an accu rate positioning with reliable efficacy in the treatment of hypovascular liver cancer, which could improve the local control rate and survival rate of hypovascular liver cancer.

关 键 词：肝肿瘤 消融技术 体层摄影术 X线计算机 

分 类 号：R735.7[医药卫生—肿瘤] R730.44[医药卫生—临床医学]